WallStreetZenWallStreetZen

NASDAQ: ATHA
Athira Pharma Inc Stock Ownership - Who owns Athira Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Athira Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert RenningerVP of Finance2025-01-022,881$0.56
$1.62kSell
Mark James LittonPresident and CEO2025-01-0225,107$0.56
$14.11kSell
Mark WorthingtonGeneral Counsel and CCO2025-01-028,510$0.56
$4.78kSell
Kevin ChurchCHIEF SCIENTIFIC OFFICER2025-01-028,510$0.56
$4.78kSell
Martin Javier SanCHIEF MEDICAL OFFICER2025-01-0210,826$0.56
$6.08kSell
Robert RenningerVP of Finance2024-11-183,651$0.55
$2.01kBuy
Kevin ChurchCHIEF SCIENTIFIC OFFICER2024-11-189,920$0.55
$5.46kBuy
Mark WorthingtonGeneral Counsel and CCO2024-11-183,651$0.55
$2.01kBuy
Rachel LeningtonCOO and CDO2024-09-052,525$0.57
$1.43kSell
Andrew GengosCFO and Chief Business Officer2024-09-051,272$0.57
$719.95Sell

1 of 2

ATHA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATHA insiders and whales buy or sell their stock.

ATHA Shareholders

What type of owners hold Athira Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC13.84%5,402,964$1.62MInsider
Perceptive Advisors LLC13.84%5,402,964$1.62MInstitution
Joseph Edelman7.98%3,114,805$934.44kInsider
Bml Capital Management LLC7.11%2,775,885$832.77kInstitution
Rtw Investments LP6.84%2,668,913$800.67kInsider
Vanguard Group Inc3.99%1,556,651$467.00kInstitution
Simplify Asset Management Inc3.82%1,492,792$447.84kInstitution
Propel Bio Management LLC3.82%1,492,792$447.84kInstitution
Tang Capital Management LLC1.54%600,000$180.00kInstitution
Blackrock Inc1.18%458,765$137.63kInstitution

1 of 3

ATHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATHA45.95%31.83%Net Buying
CSCI0.67%0.00%
ERNA0.85%99.15%Net BuyingNet Buying
ICU1.27%98.73%Net Buying
IMRN0.00%0.00%
View Top Biotech Stocks

Athira Pharma Stock Ownership FAQ

Who owns Athira Pharma?

Athira Pharma (NASDAQ: ATHA) is owned by 45.95% institutional shareholders, 31.83% Athira Pharma insiders, and 22.22% retail investors. Perceptive Advisors LLC is the largest individual Athira Pharma shareholder, owning 5.40M shares representing 13.84% of the company. Perceptive Advisors LLC's Athira Pharma shares are currently valued at $1.52M.

If you're new to stock investing, here's how to buy Athira Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.